Why is this medication prescribed?

Isatuximab-irfc injection is used along with pomalidomide (Pomalyst) and dexamethasone to treat multiple myeloma (a type of cancer of the bone marrow) in adults who have received at least two other medications, including lenalidomide (Revlimid) and a proteasome inhibitor such as bortezomib (Velcade) or carfilzomib (Kyprolis). Adults with multiple myeloma whose disease has reappeared or is not responding to at least one other treatment may also receive it coupled with dexamethasone and carfilzomib (Kyprolis). Monoclonal antibodies are a class of drugs that includes isatuximab-irfc injection. It functions by supporting the body’s efforts to impede or halt the growth of cancer cells.

How should this medicine be used?

The injection of isatuximab-irfc is administered intravenously (into a vein) by a physician or nurse. On days 1, 8, 15, and 22 of the initial 28-day cycle, it is often administered. On days 1 and 15 of a 28-day cycle following the first, it is often administered. As long as the medication keeps working and doesn’t have any serious adverse effects, this cycle may be repeated.

In order to ensure that you are not having a severe reaction to the medication, a doctor or nurse will keep a close eye on you both during and after the infusion. To assist stop reactions to isatuximab-irfc, other drugs will be administered to you. If you suffer any of the following symptoms during the infusion or up to 24 hours after receiving the infusion, call your doctor or nurse right away. nausea, wheezing, difficulty breathing, throat tightness, swelling of the face, mouth, or tongue, dizziness, lightheadedness, fainting, runny or stuffy nose, nasal congestion, cough, or chills.

It is crucial to note that the above information is a general guideline and may not cover all the specific instructions for using Isatuximab-irfc. It is essential to consult with a healthcare professional, carefully read the prescribing information and medication guide provided by the manufacturer, and follow their instructions for the correct and safe use of Isatuximab-irfc.

Other uses for this medicine

Isatuximab-irfc is not approved for any other medical conditions or indications. It is always important to consult a healthcare professional or refer to the most up-to-date prescribing information for accurate and current details about the medication’s approved uses.

What special precautions should I follow?

Regarding special precautions, it’s important to note that specific precautions may vary depending on individual circumstances, medical history, and the guidance of a healthcare professional. However, I can provide some general precautions typically associated with isatuximab-irfc:

• Allergic reactions: Patients should be monitored for signs of allergic reactions during and after the infusion of isatuximab-irfc. This can include symptoms such as fever, chills, rash, itching, difficulty breathing, or swelling.
• Infections: Isatuximab-irfc can weaken the immune system, making patients more susceptible to infections. It is essential to report any signs of infection, such as fever, cough, or persistent sore throat, to a healthcare professional.
• Infusion-related reactions: Infusion-related reactions, such as fever, chills, nausea, vomiting, and low blood pressure, may occur during the administration of isatuximab-irfc. Pre-medications may be given to help reduce these reactions.
• Blood cell count monitoring: Regular monitoring of blood cell counts, including white blood cells, red blood cells, and platelets, is typically performed during treatment with isatuximab-irfc to ensure that blood counts are within an acceptable range.
• Pregnancy and breastfeeding: Isatuximab-irfc may cause harm to unborn babies, so it is generally not recommended during pregnancy. It is also advised to avoid breastfeeding while receiving treatment with isatuximab-irfc due to potential risks to the infant.

It is important to remember that the above precautions are not exhaustive, and there may be additional precautions and considerations specific to individual patients. It is always best to consult with a healthcare professional or refer to the prescribing information and medication guide for comprehensive and accurate information about isatuximab-irfc and its precautions.

What special dietary instructions should I follow?

Regarding special dietary instructions for Isatuximab-irfc injection, there are no specific dietary restrictions associated with this medication. However, it is always a good idea to maintain a healthy and balanced diet while undergoing any medical treatment. It’s important to consult with your healthcare provider or a registered dietitian for personalized dietary recommendations based on your overall health and medical condition.

What should I do if I forget a dose?

If you forget a dose of Isatuximab-irfc, it is essential to contact your healthcare provider or follow the instructions they have given you. They will be able to provide guidance on what steps to take based on your specific situation. It is not recommended to make any changes to your medication schedule without consulting your healthcare provider. They can advise you on the best course of action to ensure you receive the appropriate treatment.

What side effects can this medication cause?

Like any medication, Isatuximab-irfc can have potential side effects. It’s important to note that not all people will experience these side effects, and the severity and frequency of side effects can vary from person to person. It’s best to consult with a healthcare professional for personalized information and advice. That being said, here are some potential side effects associated with Isatuximab-irfc:

• Infusion-related reactions: Isatuximab-irfc is administered as an intravenous infusion, and infusion-related reactions can occur during or shortly after the infusion. These reactions may include fever, chills, nausea, vomiting, headache, fatigue, itching, rash, and difficulty breathing. The healthcare team will monitor for these reactions during the infusion and may take measures to manage or prevent them.
• Infections: Isatuximab-irfc may increase the risk of infections. Common signs of infection include fever, cough, sore throat, urinary tract infection symptoms, and signs of skin infection. It’s important to promptly report any signs of infection to a healthcare provider.
• Hematologic effects: Isatuximab-irfc can affect blood cell counts. This may result in decreased levels of red blood cells (anemia), white blood cells (neutropenia), and/or platelets (thrombocytopenia). These changes can lead to symptoms such as fatigue, increased susceptibility to infections, and increased risk of bleeding. Regular blood tests are typically done to monitor these parameters.
• Gastrointestinal effects: Common gastrointestinal side effects of Isatuximab-irfc include nausea, vomiting, diarrhea, constipation, and abdominal pain. These symptoms can usually be managed with supportive care or medications.
• Fatigue: Fatigue or tiredness is a common side effect of many cancer treatments, including Isatuximab-irfc. It’s important to get enough rest and seek support from healthcare providers for managing fatigue.
• Other side effects: Isatuximab-irfc may also cause other less common side effects, including muscle or joint pain, dizziness, peripheral neuropathy (numbness or tingling in the hands or feet), eye problems, and skin reactions.

It’s important to communicate any side effects experienced during Isatuximab-irfc treatment to a healthcare provider. They can provide guidance on managing side effects and may adjust the treatment plan if needed.

What should I know about storage and disposal of this medication?

Storage:

• Isatuximab-irfc should be stored in the refrigerator between 2°C and 8°C (36°F and 46°F).
• Do not freeze the medication.
• Keep it in the original carton to protect it from light.
• Do not shake the vial or transfer the medication to another container.

Disposal:

• Unused or expired Isatuximab-irfc should be properly disposed of.
• Follow your local guidelines for medication disposal or consult with a healthcare professional.
• Do not dispose of the medication in the regular household trash or flush it down the toilet, unless specifically instructed to do so.

In case of emergency/overdose

• If you believe you or someone else has overdosed on Isatuximab-irfc, immediately call your local emergency services or go to the nearest emergency room.
• It is helpful to have the original packaging or any remaining medication with you to provide information to healthcare professionals.

What other information should I know?

• Isatuximab-irfc is administered through intravenous (IV) infusion by a healthcare professional. It should not be self-administered.
• Before using Isatuximab-irfc, inform your healthcare provider about any allergies, medical conditions, or other medications you are currently taking.
• Inform your healthcare provider about any side effects experienced during the treatment.
• Regular blood tests may be conducted to monitor your response to the medication and detect any potential complications.
• It is essential to follow your healthcare provider’s instructions regarding dosage, frequency, and duration of treatment.

Remember, the information provided here is a general guideline. Always consult your healthcare provider or the prescribing physician for specific instructions and any concerns related to the storage, disposal, emergency situations, or usage of Isatuximab-irfc.